SANUWAVE Health, Inc. Other Nonoperating Income (Expense)
SANUWAVE Health, Inc. (SNWV) reported Other Nonoperating Income (Expense) of -$396.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06
- SANUWAVE Health, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$396.00K.
- SANUWAVE Health, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$315.00K.
- SANUWAVE Health, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $5.78M.
- SANUWAVE Health, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $8.79M.
- SANUWAVE Health, Inc. other nonoperating income (expense) for fiscal 2025 was $6.95M.
- SANUWAVE Health, Inc. other nonoperating income (expense) for fiscal 2024 was -$36.90M.
- SANUWAVE Health, Inc. other nonoperating income (expense) for fiscal 2023 was -$25.26M.
- SANUWAVE Health, Inc. other nonoperating income (expense) for fiscal 2022 was -$1.34M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$396.00K 10-Q · filed 2026-08-06 | -$711.00K 10-Q · filed 2026-08-06 | $5.06M derived: sum of 3 quarters · filed 2026-08-06 | $13.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$315.00K 10-Q · filed 2026-05-12 | $5.46M derived: sum of 2 quarters · filed 2026-05-12 | $14.24M derived: sum of 3 quarters · filed 2026-05-12 | $13.36M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $5.78M derived: 10-K 12 month − 10-K 9 month · filed 2026-03-26 | $14.56M derived: sum of 2 quarters · filed 2026-03-26 | $13.67M derived: sum of 3 quarters · filed 2026-08-06 | $6.95M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $8.79M 10-K · filed 2026-03-26 | $8.86M 10-Q · filed 2025-11-06 | $7.90M derived: sum of 2 quarters · filed 2026-08-06 | $1.18M 10-K · filed 2026-03-26 | $1.37M 10-Q · filed 2025-11-06 | -$14.11M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$887.00K 10-Q · filed 2026-08-06 | -$822.00K 10-Q · filed 2025-08-07 | -$7.61M 10-Q · filed 2026-08-06 | -$7.48M 10-Q · filed 2025-08-07 | -$22.90M derived: sum of 3 quarters · filed 2026-08-06 | -$45.55M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$6.72M 10-Q · filed 2026-05-12 | -$6.66M 10-Q · filed 2025-05-08 | -$22.01M derived: sum of 2 quarters · filed 2026-05-12 | -$44.66M derived: sum of 3 quarters · filed 2026-05-12 | -$40.12M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | -$15.29M derived: 10-K 12 month − 10-K 9 month · filed 2026-03-26 | -$37.94M derived: sum of 2 quarters · filed 2026-03-26 | -$33.40M derived: sum of 3 quarters · filed 2026-03-26 | -$36.90M 10-K · filed 2026-03-26 | -$36.76M 10-K · filed 2025-03-20 | |||
| 2024-09-30 | -$22.65M 10-K · filed 2026-03-26 | -$22.61M 10-Q · filed 2024-11-07 | -$18.11M derived: sum of 2 quarters · filed 2026-03-26 | -$21.61M 10-K · filed 2026-03-26 | -$21.52M 10-Q · filed 2024-11-07 | -$4.41M derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-06-30 | $4.54M 10-K · filed 2026-03-26 | $4.57M 10-Q · filed 2024-08-12 | $1.03M 10-K · filed 2026-03-26 | $1.09M 10-Q · filed 2024-08-12 | $18.23M derived: sum of 3 quarters · filed 2026-03-26 | -$4.93M derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-03-31 | -$3.50M 10-K · filed 2026-03-26 | -$3.48M 10-Q · filed 2024-05-09 | $13.70M derived: sum of 2 quarters · filed 2026-03-26 | -$9.47M derived: sum of 3 quarters · filed 2026-03-26 | -$17.67M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2023-12-31 | $17.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$5.97M derived: sum of 2 quarters · filed 2025-03-20 | -$14.16M derived: sum of 3 quarters · filed 2025-03-20 | -$25.26M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$23.17M 10-Q · filed 2024-11-07 | -$31.36M derived: sum of 2 quarters · filed 2024-11-07 | -$42.46M 10-Q · filed 2024-11-07 | -$46.70M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$8.19M 10-Q · filed 2024-08-12 | -$19.30M 10-Q · filed 2024-08-12 | -$23.53M derived: sum of 3 quarters · filed 2024-08-12 | -$22.18M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$11.10M 10-Q · filed 2024-05-09 | -$15.33M derived: sum of 2 quarters · filed 2024-05-09 | -$13.99M derived: sum of 3 quarters · filed 2024-05-09 | -$9.30M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$2.89M derived: sum of 2 quarters · filed 2024-03-21 | $1.81M derived: sum of 3 quarters · filed 2024-03-21 | -$1.34M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $1.35M 10-Q · filed 2023-11-09 | $1.43M 10-Q · filed 2022-11-14 | $6.04M derived: sum of 2 quarters · filed 2023-11-09 | $2.89M 10-Q · filed 2023-11-09 | $3.11M 10-Q · filed 2022-11-14 | -$4.20M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $4.69M 10-Q · filed 2023-08-10 | $4.77M 10-Q · filed 2022-08-12 | $1.55M 10-Q · filed 2023-08-10 | $1.69M 10-Q · filed 2022-08-12 | -$5.54M derived: sum of 3 quarters · filed 2023-08-10 | -$6.45M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$3.15M 10-Q · filed 2023-05-11 | -$3.08M 10-Q · filed 2022-05-26 | -$10.23M derived: sum of 2 quarters · filed 2023-05-11 | -$11.14M derived: sum of 3 quarters · filed 2023-05-11 | -$15.71M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$8.00M derived: sum of 2 quarters · filed 2023-03-31 | -$12.56M derived: sum of 3 quarters · filed 2023-03-31 | -$13.09M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$911.00K 10-Q · filed 2022-11-14 | -$5.47M derived: sum of 2 quarters · filed 2022-11-14 | -$6.00M 10-Q · filed 2022-11-14 | -$4.90M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$4.56M 10-Q · filed 2022-08-12 | -$5.09M 10-Q · filed 2022-08-12 | -$3.99M derived: sum of 3 quarters · filed 2022-08-12 | -$10.26M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$527.00K 10-Q · filed 2022-05-26 | $572.00K derived: sum of 2 quarters · filed 2022-05-26 | -$5.70M derived: sum of 3 quarters · filed 2022-05-26 | -$6.06M derived: sum of 4 quarters · filed 2022-05-26 | ||||
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-13 | -$5.17M derived: sum of 2 quarters · filed 2022-05-13 | -$5.53M derived: sum of 3 quarters · filed 2022-05-13 | -$5.74M 10-K · filed 2022-05-13 | -$5.74M 10-K · filed 2021-10-21 | |||
| 2020-09-30 | -$6.27M 10-Q · filed 2022-02-28 | -$242.96K 10-Q · filed 2020-11-23 | -$6.63M derived: sum of 2 quarters · filed 2022-02-28 | -$6.84M 10-Q · filed 2022-02-28 | -$808.64K 10-Q · filed 2020-11-23 | -$7.06M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | -$359.00K 10-Q · filed 2022-01-14 | -$566.00K 10-Q · filed 2022-01-14 | -$786.33K derived: sum of 3 quarters · filed 2022-01-14 | -$1.15M derived: sum of 4 quarters · filed 2022-01-14 | ||||
| 2020-03-31 | -$206.00K 10-Q · filed 2021-12-13 | -$427.33K derived: sum of 2 quarters · filed 2021-12-13 | -$789.69K derived: sum of 3 quarters · filed 2021-12-13 | |||||
| 2019-12-31 | -$221.33K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-10-21 | -$583.69K derived: sum of 2 quarters · filed 2021-10-21 | -$1.64M 10-K · filed 2021-10-21 | |||||
| 2019-09-30 | -$362.36K 10-Q/A · filed 2021-07-01 | -$1.41M 10-Q/A · filed 2021-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |